Skip to content

Inbiose

Active
Public limited companyfounded 2013active for 13 yearsTechnologiepark-Zwijnaarde 82, 9052 Gent, Belgium32 active companies are registered at this addressKBO/BCE: BE 0534.887.593
Summary

Inbiose has been active since 2013 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €3.6m and a net result of -€1.6m. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 17% of 317 sector peers (NACE 20, financial year 2025). The computed 12-month bankruptcy probability is 0.6% (low).

Overview

Activity
Manufacture of chemicals and chemical products
NACE 20590Research and development on biotechnology NACE 72101
1 site
Size
€6.3mturnover 2025
Staff
46.1 FTE
Equity
€3.6m
Loss
-€1.6m
Financial health
70 Healthy Checked score 2025
Bankruptcy probabilitywithin 12 months
0.6%
Structure
Largest shareholder
FEDERALE PARTICIPATIE- EN INVESTERINGSMAATSCHAPPIJ · 37.45%
Board
10 members
Holdings
1
  • SoetaertChair · permanent representative Wim Soetaert
Auditor: Baker Tilly BedrijfsrevisorenAccounts 21 days early
Why 70raises riskLoss of €1.6m, the second in a row (financial year 2025)Equity €3.6m (21.2% of total assets)lowers riskFounded in 2013Legal form: public limited companyShow the evidence

Checked score

Score 2025
70 / 100
Healthy
Probability in this band: 0.55% to 1.5%
Financially better than 50% of its sector peers (NACE 20, small)
Financial strength · tick = 2024
Average
Solvency 46+46
equity 21.2% of total assets
Liquidity 54+10
short-term debt 22.6% · cash 9.5%
Profitability 50+50
return on assets -9.3%
Bankruptcy probability, 12 months
0.6% Low
0%0.5%1.5%4%10%≥ 25%

About 6 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.1% (147 companies, NACE 20, small)
Last 24 months 11-2024: 2.6% 12-2024: 2.6%● unchanged vs 11-2024 01-2025: 2.6%● unchanged vs 12-2024 02-2025: 2.6%● unchanged vs 01-2025 03-2025: 2.7%▲ +0.1 percentage points vs 02-2025 04-2025: 2.7%● unchanged vs 03-2025 05-2025: 2.7%● unchanged vs 04-2025 06-2025: 2.8%▲ +0.1 percentage points vs 05-2025 07-2025: 2.9%▲ +0.1 percentage points vs 06-2025highest value 08-2025: 2.7%▼ -0.2 percentage points vs 07-2025 09-2025: 2.7%● unchanged vs 08-2025 10-2025: 2.7%● unchanged vs 09-2025 11-2025: 2.7%● unchanged vs 10-2025 12-2025: 2.7%● unchanged vs 11-2025 01-2026: 2.7%● unchanged vs 12-2025 02-2026: 2.7%● unchanged vs 01-2026 03-2026: 2.6%▼ -0.1 percentage points vs 02-2026 04-2026: 2.6%● unchanged vs 03-2026 05-2026: 2.6%● unchanged vs 04-2026 06-2026: 2.7%▲ +0.1 percentage points vs 05-2026 07-2026: 2.8%▲ +0.1 percentage points vs 06-2026 08-2026: 0.6%▼ -2.2 percentage points vs 07-2026lowest value 09-2026: 0.6%● unchanged vs 08-2026lowest value 10-2026: 0.6%● unchanged vs 09-2026lowest value
Credit of up to €250,000 on 30-day terms is acceptable
Liquidity tight (current ratio 1.49, compared with 0.74 in 2024; short-term debt: 22.6% and cash: 9.5% of total assets), and 78.8% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 20, small): better than 17% on solvency, 63% on liquidity, 22% on profitability and 99% on growth.

The bankruptcy probability was computed on 12-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
raises risk · Loss of €1.6m, the second in a row (financial year 2025)
NBB · annual accounts
lowers risk · Founded in 2013
Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.
KBO
raises risk · Equity €3.6m (21.2% of total assets)
NBB · annual accounts
lowers risk · Legal form: public limited company
KBO
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 17% of 317 sector peers (2025).
NBB · sector comparison
Position among 317 sector peers
Solvency
better than 17%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 10-07-2026, 21 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
21 days early
2024
16 days early
2023
54 days early
2022
38 days early
2021
11 days early
2020
24 days early
2019
51 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 31 days before the deadline; the sector median (NACE 20) for financial year 2024 is 22 days before the deadline, and 27% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 10 July (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
12-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Reappointment: Baker Tilly Bedrijfsrevisoren (statutory auditor)Permanent representative: Christel De Blander…
  2. Annual accounts filedfinancial year 2025 · full…
  3. Resignations: Friday Consulting, Delcourt,Clemence and Dirk…Permanent representatives: Freitag,Barbara and Abeel,Dirk…

Key points

  • Risk: 8 loss-making years in a rowloss financial year 2025 -€1.6m View
  • Positive: Turnover rose in 2025from €2.0m to €6.3m ▲ 209% View
  • Caution: Among the weakest 10% on net resultsector median €461,868 · 318 companies -€1.6m View
  • Board changedlatest change 22-05-2026 · 10 in office 3 joined · 4 left View
  • Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View
  • EU research moneyEU contribution €4.3m View

By topic

Financials

Financial year
2025
Turnover
€6.3m
Loss
-€1.6m
Solvency
21.2%
Turnover▲ 209%
Net result
20232025
Go to Financials

Board & ownership

Board
10 members
Largest shareholder
FEDERALE PARTICIPATIE- EN INVESTERINGSMAATSCHAPPIJ · 37.45%
Auditor
Baker Tilly Bedrijfsrevisoren
  • SoetaertChair
  • Federale Participatie- en InvesteringsmaatschappijDirector
  • Marc ZabeauDirector
  • Jean PrevotDirector
  • Joeri BeauprezDirector

and 5 other directors

Go to Board & ownership

Timeline

Events
37
Since
2013
Next accounts
by 31-07-2027
  1. 20-03-2026Resignations: Friday Consulting BV (ceo bestuurder) and…
  2. 31-12-2025Liquidity doubles
  3. 31-12-2025Equity above €2m
Go to Timeline

Company details

Sites
1
Legal form
Public limited company
Activity
Manufacture of chemicals and chemical productsNACE 20590
Founded
31-05-2013
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Articles of association

Provisions read
29
Annual meeting
25 May at 10:00
Purpose
“Technologische ontwikkeling,productie en commercialisering van biogebaseerde…” (deed in Dutch)
Go to Articles of association

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.